Ligand Pharmaceuticals, Inc. (LGND)

213.21 -5.77 (-2.63%) USD  |  NASDAQ  |  May 15, 16:00
212.00 -1.21 (-0.57%) After-Hours: 20:00
More

Ligand Pharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Johnson & Johnson Upgrade
Organon & Co. Upgrade
Merck & Co., Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade